![logo](/logos/NTI.AX.webp)
Neurotech International Limited
ASX:NTI.AX
0.07 (AUD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Neurotech International Limited |
Symbool | NTI.AX |
Munteenheid | AUD |
Prijs | 0.068 |
Beurswaarde | 69,196,120 |
Dividendpercentage | 0% |
52-weken bereik | 0.051 - 0.125 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Alexandra Andrews |
Website | https://www.neurotechinternational.com |
An error occurred while fetching data.
Over Neurotech International Limited
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)